Purchases and Sales Made in Q3 2022 in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE) during Q3 2022. The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-6.82K- 17.01% |
$48.9K - $83K
|
33.3K
$221K
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-7.5K- 28.39% |
$53.8K - $91.2K
|
18.9K
$126K
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-10K- 9.87% |
$71.9K - $122K
|
91.6K
$608K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-17.5K- 12.55% |
$126K - $213K
|
122K
$811K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-19.9K- 15.77% |
$143K - $242K
|
106K
$706K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-855K- 37.79% |
$6.13M - $10.4M
|
1.41M
$9.35M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.49M- 28.3% |
$10.7M - $18.1M
|
3.76M
$25M
|